Yeah still need to run trials and submit all the evidence etc. The designation speeds the approval status up though and there are tax benefits and exclusivity benefits.
Still coming up to speed with all this so DYOR
PharmD
- Forums
- ASX - By Stock
- PAR
- New orphan drug designation
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
2.38%
!
41.0¢

New orphan drug designation, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
41.0¢ |
Change
-0.010(2.38%) |
Mkt cap ! $162.9M |
Open | High | Low | Value | Volume |
42.0¢ | 42.3¢ | 39.5¢ | $453.0K | 1.114M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49347 | 41.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.0¢ | 70000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2500 | 0.410 |
4 | 21500 | 0.400 |
5 | 92140 | 0.395 |
4 | 46650 | 0.390 |
4 | 79000 | 0.385 |
Price($) | Vol. | No. |
---|---|---|
0.400 | 35500 | 1 |
0.415 | 14173 | 1 |
0.420 | 51400 | 2 |
0.425 | 9000 | 2 |
0.430 | 28500 | 1 |
Last trade - 16.10pm 17/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |